Lixisenatide
Effects of a GLP-1 Receptor Agonist on Functional Activation and Connectivity of the Brain
Sanofi · Not applicable · Completed · Enrollment 30
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Lixisenatide injection | n/r | n/r | n/r | n/r |
| Normal saline | n/r | n/r | n/r | n/r |
Not shown
- Lixisenatide injection: endpoint not reported
- Normal saline: endpoint not reported